Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- HILS
- Price
- -
- Stock movement down
- -0.14 (-4.80%)
- Company name
- Hillstream Biopharma Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 50.61M
- Ent value
- 49.33M
- Price/Sales
- -
- Price/Book
- 28.80
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -72.85%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2024-12-17
DIVIDENDS
HILS does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 28.80 |
| EV to Sales | - |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 17.60M |
| EPS (TTM) | -92.69 |
| FCF per share (TTM) | -0.61 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | 0.00 |
| Operating income (TTM) | -8.69M |
| Net income (TTM) | -1.60B |
| EPS (TTM) | -92.69 |
| EPS (1y forward) | -0.15 |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 2.69M |
| Net receivables | 0.00 |
| Total current assets | 3.17M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 3.17M |
| Accounts payable | 1.14M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 1.41M |
| Total liabilities | 1.41M |
| Shareholder's equity | 1.76M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -6.95M |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | -10.62M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -91238.83% |
| Return on Assets | -50616.38% |
| Return on Invested Capital | -91238.83% |
| Cash Return on Invested Capital | -604.31% |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| HILS | S&P500 | |
| Current price drop from All-time high | -97.34% | -4.69% |
| Highest price drop | -97.34% | -56.47% |
| Date of highest drop | 24 Nov 2023 | 9 Mar 2009 |
| Avg drop from high | -77.56% | -11.07% |
| Avg time to new high | 47 days | 12 days |
| Max time to new high | 452 days | 1805 days |
COMPANY DETAILS
Marketcap
50.61M
Marketcap category
Small-cap
Description
Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) and targeted immuno-oncology novel biologics for the treatment drug resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors. It also develops HSB-3215, an anti-HER2 monoclonal antibody candidate; and HSB-1940, a Quatrabody that is a proprietary IO biologic in development targeting PD-1. The company was incorporated in 2017 and is based in Bridgewater, New Jersey.
Employees
1
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner